Clinical Trial Update: Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA) [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting on the efficacy and safety of lumiracoxib in patients with primary knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Lumiracoxib (Lumiracoxib)

Snippet

Sponsor: Novartis | Conditions: Osteoarthritis | Phase 3 | Status: COMPLETED